Association of family history and survival in patients with colorectal cancer.

Authors

null

Dawn Q. Chong

Massachusetts General Hospital and Harvard Medical School, Boston, MA

Dawn Q. Chong , Barbara L. Banbury , Amanda I. Phipps , Xinwei Hua , Jonathan Kocarnik , Ulrike Peters , Sonja Berndt , Wen-Yi Huang , John D. Potter , Martha L. Slattery , Emily White , Peter T. Campbell , Tabitha A. Harrison , Polly A. Newcomb , Andrew T. Chan

Organizations

Massachusetts General Hospital and Harvard Medical School, Boston, MA, Fred Hutchinson Cancer Research Center, Seattle, WA, National Cancer Institute, National Institutes of Health, Bethesda, MD, University of Utah Health Sciences Center, Salt Lake City, UT, American Cancer Society, Atlanta, GA

Research Funding

NIH

Background: A family history of colorectal cancer (CRC) in first-degree relatives (FDRs) increases the risk of CRC. However, beyond rare hereditary CRC syndromes, the influence of family history on CRC survival remains uncertain. Methods: We conducted a pooled analysis of 5,010 incident CRC cases from 6 prospective cohort studies and 2 population-based case-control studies within the International Survival Analysis in CRC Consortium (ISACC). Cox proportional hazards models were used to estimate overall survival (OS) and CRC-specific survival (CSS) in relation to family history of CRC in FDRs, and number of affected FDRs, adjusting for age, gender, body mass index, smoking status, use of aspirin/non-steroidal anti-inflammatory drugs, history of screening endoscopy, stage at diagnosis, tumor location and study site. We conducted subgroup analyses by age, gender, tumor location and stage. Results: 819 (16.3%) patients reported a family history of CRC. There were 1,580 (31.5%) total deaths over a median follow-up time of 4.6 years, of which 1,046 (66.2%) were due to CRC. Individuals with a family history of CRC were more likely to have undergone screening endoscopy (p < 0.001), have proximal colon tumors (p = 0.04) and non-metastatic CRC (p = 0.003). Having a family history of CRC was not associated with OS [hazard ratio (HR) 1.03; 95% confidence interval (CI) 0.89-1.19] or CSS (HR 1.13; 95% CI 0.95-1.36) after multivariate adjustment. Compared to patients without a family history, those with ≥ 2 affected FDRs had a HR of 0.92 (95% CI 0.59-1.43) for OS, and HR of 0.98 (95% CI 0.55-1.76) for CSS. There was no association between age at diagnosis of the affected FDR with OS (ptrend = 0.47) or CSS (ptrend = 0.16). In subgroup analyses, family history was associated with worse CSS in individuals diagnosed at age ≤ 70 years (HR 1.45; 95% CI 1.11-1.89), and in patients with distal colon cancer (HR 1.45; 95% CI 1.03-2.04). Conclusions: Among CRC patients,family history is generally not associated with CRC survival. However, family history may be associated with worse prognosis in individuals diagnosed at age ≤ 70 years, and in patients with distal colon cancer, suggesting a possible distinct pathogenic mechanism underlying a common genetic predisposition.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3594)

DOI

10.1200/JCO.2016.34.15_suppl.3594

Abstract #

3594

Poster Bd #

291

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Rates of colorectal cancer screening versus lung cancer screening: Where does the problem lie?

First Author: Sasmith R. Menakuru

Abstract

2023 ASCO Quality Care Symposium

Association of health insurance coverage disruptions and breast, colorectal, and cervical cancer screening.

First Author: Kewei Sylvia Shi

Abstract

2024 ASCO Annual Meeting

Cost effectiveness of colorectal cancer screening in the Dominican Republic.

First Author: Yoanna S. Pumpalova

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Trends in colorectal cancer screening from NHIS survey: Analysis of modalities impact on overall screening.

First Author: Derek W. Ebner